Gemfibrozil Tablet
Product Images NDC 68382-553

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 68382-553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (35b23d65 7fe3 4cf2 B657 08982788b4bd 01)

Chemical structure diagram of Gemfibrozil showing its molecular arrangement with methyl groups, phenyl ring, and carboxylic acid functional group as part of the molecule.*

FDA Label Image

Label (35b23d65 7fe3 4cf2 B657 08982788b4bd 02)

Label for Gemfibrozil Tablets, USP 600 mg oral tablets by Zydus Pharmaceuticals. The label indicates a package containing 30 tablets, Rx only. It includes directions to store between 20° to 25°C, protect from light and humidity, and keep out of reach of children. Manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.